arrow
J

Joseph P. Nkolola

Beth Israel Deaconess Medical Center
H指数:38
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase 1 and preclinical studies reveal safety; pharmacokinetics; and efficacy of intranasal delivery of the influenza antibody CR9114
2026-02-040
PRE
Immunopathogenesis of lethal H5N1 avian influenza virus clade 2.3.4.4b infection in macaques

猕猴中致死性H5N1禽流感病毒2.3.4.4b进化枝感染的免疫发病机制

Immunity
IF26.3
2025-08-180
OAAI
Safety and antiviral effect of a triple combination of HIV-1 broadly neutralizing antibodies: a phase 1/2a trial
2024-09-121
OA
Immunogenicity of 2 therapeutic mosaic HIV-1 vaccine strategies in individuals with HIV-1 on antiretroviral therapy
2024-05-230
OAAI
Therapeutic efficacy of combined active and passive immunization in ART-suppressed, SHIV-infected rhesus macaques
2022-06-1620
OAAI
Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaques
2022-05-187
OAAI
Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial
2022-05-1270
OAAI
A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques
MED
IF11.8
2022-03-0112
OAAI
Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial
2021-10-0750
OAAI
Validation of a Triplex Pharmacokinetic Assay for Simultaneous Quantitation of HIV-1 Broadly Neutralizing Antibodies PGT121, PGDM1400, and VRC07-523-LS
2021-08-2410
OAAI
Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women
2021-06-15301
OA